Manulife (Manufacturers Life Insurance)’s Mirum Pharmaceuticals MIRM Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio MIRM Stock Details MIRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8.75M	Buy	74,750 +19,057	+34%	+$1.91M	0.01%	954
2026 Q1	$5.14M	Buy	55,693 +21,579	+63%	+$2.03M	﹤0.01%	1156
2025 Q4	$2.69M	Buy	34,114 +5,624	+20%	+$404K	﹤0.01%	1409
2025 Q3	$2.09M	Buy	28,490 +5,697	+25%	+$362K	﹤0.01%	1502
2025 Q2	$1.16M	Buy	22,793 +440	+2%	+$19.6K	﹤0.01%	1753
2025 Q1	$1.01M	Buy	22,353 +728	+3%	+$34.3K	﹤0.01%	1805
2024 Q4	$894K	Sell	21,625 -488	-2%	-$20.3K	﹤0.01%	1959
2024 Q3	$862K	Sell	22,113 -21	-0.1%	-$838	﹤0.01%	1995
2024 Q2	$757K	Sell	22,134 -22,057	-50%	-$578K	﹤0.01%	2003
2024 Q1	$1.11M	Buy	44,191 +5,667	+15%	+$156K	﹤0.01%	1804
2023 Q4	$1.14M	Buy	38,524 +27,830	+260%	+$842K	﹤0.01%	1733
2023 Q3	$338K	Sell	10,694 -29	-0.3%	-$794	﹤0.01%	2315
2023 Q2	$277K	Buy	+10,723	New	+$285K	﹤0.01%	2410

Other funds holding MIRM

FLSM

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

Jupiter Topco New York $245B AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s MIRM Position: Q2 2026 in Review

Manulife (Manufacturers Life Insurance) increased its Mirum Pharmaceuticals (MIRM) stake by 34% in Q2 2026, buying an estimated $1.91M and bringing the position to 74,750 shares worth $8.75M. The position accounts for 0.01% of the portfolio, ranked #954.

Manulife (Manufacturers Life Insurance) first reported a position in MIRM in Q2 2023 and has held it in 13 quarters since. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

Manulife (Manufacturers Life Insurance) held 74,750 shares of Mirum Pharmaceuticals worth $8.75M as of Q2 2026.
Manulife (Manufacturers Life Insurance) bought 19,057 Mirum Pharmaceuticals shares in Q2 2026, an estimated $1.91M.
Mirum Pharmaceuticals made up 0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q2 2026, its #954 holding.
Manulife (Manufacturers Life Insurance) first reported a position in Mirum Pharmaceuticals in Q2 2023 and has held it in 13 quarters since.
327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2026, filed 14 Aug 2026.